Cargando…

Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study

BACKGROUND: To determine if recommended treatment targets, as specified in clinical practice guidelines for the management of cardiovascular disease, reduces the risk of renal complications in high risk patient populations. METHODS: This was a cohort study. Participants in Utrecht, The Netherlands e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Selvarajah, Sharmini, vD Graaf, Yolanda, Visseren, Frank LJ, Bots, Michiel L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141761/ https://www.ncbi.nlm.nih.gov/pubmed/21729268 http://dx.doi.org/10.1186/1471-2261-11-40

Ejemplares similares

Multifocal cardiovascular calcification in patients with established cardiovascular disease; prevalence, risk factors, and relation with recurrent cardiovascular disease
por: van 't Klooster, Cilie C., et al.
Publicado: (2020)

Identification of effective screening strategies for cardiovascular disease prevention in a developing country: using cardiovascular risk-estimation and risk-reduction tools for policy recommendations
por: Selvarajah, Sharmini, et al.
Publicado: (2013)

Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
por: de Vries, Tamar Irene, et al.
Publicado: (2021)

Risk Factor Clusters and Cardiovascular Disease in High-Risk Patients: The UCC-SMART Study
por: Holthuis, Emily I., et al.
Publicado: (2021)

An Asian Validation of the TIMI Risk Score for ST-Segment Elevation Myocardial Infarction
por: Selvarajah, Sharmini, et al.
Publicado: (2012)

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

Added value of cardiovascular calcifications for prediction of recurrent cardiovascular events and cardiovascular interventions in patients with established cardiovascular disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2021)

The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease
por: Schrover, Ilse M, et al.
Publicado: (2018)

Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease
por: Kranendonk, Mariëtte EG, et al.
Publicado: (2014)

Blood pressure and cholesterol measurements in primary care: cross-sectional analyses in a dynamic cohort
por: de Boer, Annemarijn R, et al.
Publicado: (2022)

The association between a genetic variant in the SULF2 gene, metabolic parameters and vascular disease in patients at high cardiovascular risk
por: Heidemann, Britt E, et al.
Publicado: (2023)

The effect of computerized decision support systems on cardiovascular risk factors: a systematic review and meta-analysis
por: Groenhof, T. Katrien J., et al.
Publicado: (2019)

Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2020)

The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease
por: Groenland, Eline H., et al.
Publicado: (2022)

Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study
por: Verhagen, Sandra N, et al.
Publicado: (2011)

End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study
por: Østergaard, Helena Bleken, et al.
Publicado: (2021)

Targeted proteomics improves cardiovascular risk prediction in secondary prevention
por: Nurmohamed, Nick S., et al.
Publicado: (2022)

Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care
por: de Beus, Esther, et al.
Publicado: (2017)

The relationship between walking speed and changes in cardiovascular risk factors during a 12-day walking tour to Santiago de Compostela: a cohort study
por: Bemelmans, Remy H H, et al.
Publicado: (2012)

Use of a Diagnostic Score to Prioritize Computed Tomographic (CT) Imaging for Patients Suspected of Ischemic Stroke Who May Benefit from Thrombolytic Therapy
por: Hwong, Wen Yea, et al.
Publicado: (2016)

Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease
por: van de Woestijne, Anton P., et al.
Publicado: (2014)

Use of Antihypertensive Drugs and Ischemic Stroke Severity – Is There a Role for Angiotensin-II?
por: Hwong, Wen Yea, et al.
Publicado: (2016)

Prescription of secondary preventive drugs after ischemic stroke: results from the Malaysian National Stroke Registry
por: Hwong, Wen Yea, et al.
Publicado: (2017)

Trends of Stroke Incidence and 28-Day All-Cause Mortality after a Stroke in Malaysia: A Linkage of National Data Sources
por: Hwong, Wen Yea, et al.
Publicado: (2021)

Arterial stiffness as a risk factor for cardiovascular events and all‐cause mortality in people with Type 2 diabetes
por: Sharif, S., et al.
Publicado: (2019)

Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension
por: van Kleef, Monique E. A. M., et al.
Publicado: (2020)

Stepwise implementation of a cardiovascular risk management care program in primary care
por: Smits, Geert, et al.
Publicado: (2022)

A computerised decision support system for cardiovascular risk management ‘live’ in the electronic health record environment: development, validation and implementation—the Utrecht Cardiovascular Cohort Initiative
por: Groenhof, T. K. J., et al.
Publicado: (2019)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Asking informed consent may lead to significant participation bias and suboptimal cardiovascular risk management in learning healthcare systems
por: Zondag, Anna G. M., et al.
Publicado: (2023)

Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all‐cause mortality: Findings from the SMART cohort
por: Sharif, Shahnam, et al.
Publicado: (2019)

Smartphone Application-Assisted Home Blood Pressure Monitoring Compared With Office and Ambulatory Blood Pressure Monitoring in Patients With Hypertension: the AMUSE-BP Study
por: Groenland, Eline H., et al.
Publicado: (2022)

Trends in the risk of cardiovascular disease in women with breast cancer in a Dutch nationwide cohort study
por: Buddeke, Josefien, et al.
Publicado: (2019)

Cardiovascular risk reduction with integrated care: results of 8 years follow up
por: Smits, Geert H. J. M., et al.
Publicado: (2023)

The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study
por: van’t Klooster, Cilie C, et al.
Publicado: (2019)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
por: de Jong, Marit, et al.
Publicado: (2017)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
por: Touyz, Rhian M., et al.
Publicado: (2021)

Integrated cardiovascular risk management programme versus usual care in patients at high cardiovascular risk: an observational study in general practice
por: Marchal, Suzanne, et al.
Publicado: (2021)

Plasma Trough Concentrations of Antihypertensive Drugs for the Assessment of Treatment Adherence: A Meta-Analysis
por: Groenland, Eline H., et al.
Publicado: (2020)

Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
por: Stam‐Slob, Manon C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2edfpu5iddc9p55lkrpjvvtcp7